[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622710":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":25,"locations":35,"responsibleParty":51,"collaborators":53,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":18,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":18,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":38,"whyStopped":18,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Hoya Lens Rus LLC","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"MiYOSMART iQ intervention group","EXPERIMENTAL","DIMS with Triple Enhanced Design technology",[13],"Device: MiYOSMART iQ spectacle lenses",{"label":15,"type":16,"description":17,"interventionNames":18},"Historical control group","NO_INTERVENTION","Retrospective data from patients with single-vision spectacle correction",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DEVICE","MiYOSMART iQ spectacle lenses","MiYOSMART iQ are single-vision spectacle lenses made of polycarbonate (refractive index 1.59) featuring Defocus Incorporated Multiple Segments (DIMS) technology with Triple Enhanced Design (TED). The lens contains a central optical zone for clear distance vision, surrounded by multiple, uniformly distributed micro-lens segments (diameter: \\~1.00 mm) that create a consistent myopic defocus signal of +4.50 D across the peripheral retina. This specific optical design aims to slow axial elongation in progressing myopia. The intervention involves full-time wear of spectacles with these lenses. The device is CE-marked and has Russian registration certificate No. ФСЗ 2012\u002F11555 dated December 5, 2024",[9],[26,31],{"name":27,"role":28,"phone":29,"phoneExt":18,"email":30},"Elena Tarutta, MD, PhD","CONTACT","+7(916)121-19-53","Otdel_ref_bin2@igb.ru",{"name":32,"role":28,"phone":33,"phoneExt":18,"email":34},"Nikolai Makukha","+7(968)88-55-942","makuha@hoya.com",[36],{"facility":37,"status":38,"city":39,"state":18,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Helmholtz National Medical Research Center of Eye Diseases","RECRUITING","Moscow","105062","Russia","RU",{"type":44,"coordinates":45},"Point",[46,47],37.61781,55.75204,{"lat":47,"lon":46},[50],{"name":27,"role":28,"phone":29,"phoneExt":18,"email":30},{"type":52,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[54],{"name":37,"class":55},"UNKNOWN","100622710","effect-of-miyosmart-iq-spectacle-lenses-on-myopia-progression-in-children-100622710",false,"NCT07387159","Effect of MiYOSMART iQ Spectacle Lenses on Myopia Progression in Children","Prospective, Interventional, Single-center Study to Evaluate the Influence of MiYOSMART iQ Spectacle Lenses With DIMS and Triple Enhanced Design Technology on Refraction Dynamics, Biometric Parameters, Peripheral Refraction and Contrast Sensitivity in Children With Myopia","Inclusion Criteria:\n\n* Age 8-11 years (inclusive)\n* Myopia: spherical equivalent -0.5 to -6.0 D under cycloplegia\n* No previous myopia control treatment\n* Orthophoria, presence of binocular vision\n\nExclusion Criteria:\n\n* Corrected visual acuity \\\u003C 0.8 (decimal)\n* Anisometropia \\> 2.0 D\n* Strabismus history or presence\n* Previous refractive or intraocular surgery","ALL","8 Years","11 Years",{"count":67,"type":68},70,"ESTIMATED","INTERVENTIONAL",[71],"NA","This prospective, single-center study aims to evaluate the efficacy and safety of MiYOSMART iQ spectacle lenses with DIMS (Defocus Incorporated Multiple Segments) and Triple Enhanced Design (TED) technology in slowing myopia progression in children aged 8-11 years.\n\n35 children with myopia (spherical equivalent -0.5 to -6.0 D) will be prescribed MiYOSMART iQ lenses and followed for 6 months. The study will compare changes in spherical equivalent refraction and axial length against a historical control group (n=35) using ANCOVA. Secondary outcomes include measurements of peripheral refraction and contrast sensitivity at the first prescription.\n\nThe study hypothesis is that wearing MiYOSMART iQ lenses for 6 months significantly slows myopia progression compared to single-vision spectacle correction.",[74],"Myopia, Child Myopia Progression",[76],"myopia control, spectacle lenses, peripheral defocus, DIMS, MiYOSMART","2026-02-05",{"date":79,"type":80},"2026-02-06","ACTUAL",{"date":82,"type":80},"2026-02-04",{"date":84,"type":68},"2027-02-28",{"name":5,"class":6},1]